Investor Relations
Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.
-
Dec 12, 2022
2022 Investor Day
-
Aug 31, 2022
2022 Interim Results Online Conference
-
Apr 09, 2022
HBM7022 Out-license to AstraZeneca
-
Mar 25, 2022
2021 Annual Results Online Conference
Copyright © 2022 Harbour BioMed. All Rights Reserved 沪ICP备19015946号-1